BRIAN JACKSON: Open Payments
NPI 1790560589 · CONWAY, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,085 in 152 payments from 17 companies in 2025. Trend: 2023 $118 · 2024 $2,690 · 2025 $3,085
Food & beverage: $3,085
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 62 | $965 |
| Janssen Biotech, Inc. | 10 | $410 |
| Takeda Pharmaceuticals U.S.A., Inc. | 19 | $316 |
| Regeneron Healthcare Solutions, Inc. | 11 | $300 |
| Gilead Sciences, Inc. | 5 | $221 |
| Lilly USA, LLC | 7 | $207 |
| Madrigal Pharmaceuticals | 10 | $182 |
| Aimmune Therapeutics, Inc. | 8 | $168 |
| Ipsen Biopharmaceuticals, Inc | 4 | $82 |
| Intercept Pharmaceuticals, Inc. | 3 | $50 |
Products named: TREMFYA, RINVOQ, DUPIXENT, ENTYVIO, CREON, SKYRIZI, REZDIFFRA, ZENPEP.
Industry payments across AR — which companies pay providers there.
